Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor

Por Zhang, Wei-Wei, Bai, Feng, Wang, Jin, Zheng, Rong-Hua, Yang, Li-Wang, James, Erskine A, Zhao, Zhi-Qing
Publicado no Drug Des Devel Ther (2017)